Contact this trialFirst, we need to learn more about you.
Growth Hormone Therapy for Pseudohypoparathyroidism
Recruiting1 award
Hartford, Connecticut
This trial is observing the effects of growth hormone on patients with Albright hereditary osteodystrophy, specifically those with pseudohypoparathyroidism type 1a. This form of the condition typically leads to patients being short and obese. The trial is also observing the neurocognitive and psychosocial effects of the condition in order to better understand how to manage it.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service